Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 7—July 2015

Malaria Prevalence among Young Infants in Different Transmission Settings, Africa

Serign J. Ceesay, Lamine Koivogui, Alain Nahum, Makie Abdoulie Taal, Joseph Okebe, Muna Affara, Lama Eugène Kaman, Francis Bohissou, Carine Agbowai, Benoit Gniouma Tolno, Alfred Amambua-Ngwa, NFaly Bangoura, Daniel Ahounou, Abdul Khalie Muhammad, Stephan Duparc, Kamal Hamed, David Ubben, Kalifa Bojang, Jane Achan, and Umberto D’AlessandroComments to Author 
Author affiliations: Medical Research Council Unit, Fajara, The Gambia (S.J. Ceesay, J. Okebe, M. Affara, A. Amambua-Ngwa, A.K. Muhammad, K. Bojang, J. Achan, U. D’Alessandro); Institut National de Santé Publique, Conakry, Guinea (L. Koivogui, L.E. Kaman, B.G. Tolno); Centre de Recherches Entomologiques de Cotonou, Cotonou, Benin (A. Nahum, F. Bohissou, C. Agbowai, D. Ahounou); National Public Health Laboratory, Kotu, The Gambia (M.A. Taal); Préfectoral de la santé de Faranah, Guinea (N. Bangoura); Medicines for Malaria Venture, Geneva, Switzerland (S. Duparc, D. Ubben); Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA (K. Hamed); London School of Hygiene and Tropical Medicine, London, UK (U. D’Alessandro); Institute of Tropical Medicine, Antwerp, Belgium (U. D’Alessandro)

Main Article

Table 3

Anti–MSP119 antibody seropositivity and Plasmodium falciparum parasite prevalence among children in different transmission settings, Africa*

Country, age group Parasite prevalence, no. (%)† Antibody seropositive, no. (%) p value
The Gambia, N = 2,270
0–6 mo 25 (3.4) 33 (5.7) 0.044
1–9 y 8 (1.0) 53 (7.0) <0.001
10–15 y
21 (2.7)
57 (8.1)
Benin, N = 2,276
0–6 mo 25 (3.3) 269 (36.5) <0.001
1–9 y 201 (26.5) 303 (41.5) <0.001
10–15 y
284 (37.6)
311 (42.5)
Guinea, N = 2,215
0–6 mo 133 (18.4) 299 (41.6) <0.001
1–9 y 574 (76.7) 339 (45.9) <0.001
10–15 y 612 (82.4) 320 (44.2) <0.001

*MSP119, 19-kDa merozoite surface protein.
†Prevalence as determined by microscopy.

Main Article

Page created: June 12, 2015
Page updated: June 12, 2015
Page reviewed: June 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.